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Abstract 
Flavohemoglobin (FHb) is a flavoheme enzyme that catalyzes dioxygenation of nitric oxide 
(NO) to nitrate NO3
–
. NO is a diatomic radical gas produced by enzymatic and non-enzymatic 
oxidation of reduced nitrogenous compounds. NO acts as a membrane-permeable signal 
molecule in mammals. In addition it is toxic at higher concentrations and is utilized by the 
immune system against invading pathogens. FHb is involved in protection against the 
cytotoxic effects of NO (termed nitrosative stress) and is found in a range of bacterial species 
and some fungi. FHbs are not found in higher eukaryotes, but is employed by a range of 
pathogens, and is a potential therapeutic target. 
In this thesis we sought to investigate the FHb from Bacillus cereus by determination of the 
X-ray crystal structure as only a few structures of FHb from different organisms have been 
obtained. 
The protein was successfully cloned and expressed and a purification protocol has been 
developed, with ammonium sulfate precipitation, anion exchange chromatography and gel 
filtration. A high yield with high purity was obtained, but with heme and FAD at 
substoichiometric levels. Crystallization screening resulted in some small needles grown from 
precipitate, although they were non-reproducible and no crystal structure was obtained. 
A heme assay was performed in order to identify the heme/protein ratio and protein assays 
were performed to calculate protein concentration. Testing of reconstitution with heme and 
FAD was performed with promising results. 
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1 Introduction 
This thesis will start with an introduction on flavoheme proteins, more specifically about the 
heme and flavin cofactors, followed by an introduction to nitric oxide. Thereafter 
flavohemoglobin (FHb), which is the focus of this thesis, will be introduced with some focus 
on structure, catalytic mechanism and an overview of the research field. At the end of the 
introduction a more specific description of the work carried out in this thesis will be given. 
Heme and flavin cofactors 
Biological cofactors are utilized in order for enzymes to enable a wide variety of reactions 
necessary for all aspects of life. In this section the characteristics of two cofactors will be 
presented, heme and flavin. 
1.1.1 Heme 
Heme-proteins are widely used throughout the biosphere, and the heme group is a central 
molecule of life [1, 2] that is involved in a range of reactions including: catalysis, electron 
transfer and immunological defense, in addition to oxygen transport and storage,  
Heme is a prosthetic group consisting of an organic ring structure (protoporphyrin) and a 
single iron ion (figure 1.1). The four nitrogen atoms chelate the iron ion. Iron consists mainly 
in three oxidation states in biological systems: the reduced ferrous (Fe
2+
) form with oxidation 
number +2, the ferric (Fe
3+
) form with oxidation number +3 or the ferryl (Fe
4+
) form with 
oxidation state +4 [3]. There are various types of heme, which differ in their protoporphyrin. 
The most abundant type, heme b, consists of a protoporphyrin IX. The other iron porphyrins 
differ in the substitutions pointing out from the ring system. Ferric (Fe
3+
) protoporphyrin IX is 
called hemin and can be reduced by one electron to produce ferrous (Fe
2+
) heme. Heme is 
usually used as a generic term for both the ferrous (Fe
2+
) and ferric (Fe
3+
) forms of iron 
protoporphyrin IX. Formerly however, heme only referred to the ferrous form and hemin to 
the ferric [1]. 
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Figure 1.1: Heme cofactor: Heme consists of a protoporphyrin ring and a single iron ion. a) Heme b consists of 
protoporphyrin IX. b) The iron can coordinate two axial ligands, which may be Cys, His or Met residue in 
proteins or small molecules, including oxygen, nitric oxide and carbon monoxide. Taken from Zhang, Heme 
biology 2011 [1]. 
In proteins, the heme group is sequestrated in the protein structure in order to prevent 
irreversible conversion of the ferrous iron to the ferric state. The iron atom in heme can have 
up to six coordination bonds, four to the nitrogen atoms in the flat porphyrin ring and two 
perpendicular to the porphyrin. In heme proteins the iron may be 4, 5 or 6-coordinated with 
the axial ligands often being either cysteine, histidine, tyrosine or methionine and a small 
molecule [1]. 
1.1.2 Flavin 
Flavoproteins are found in bacteria, archaea and eukaryotes, with the number of genes 
encoding flavin-dependent proteins varying from 0.1% to 3.5% [4]. Flavoproteins catalyze a 
range of different reactions, and the flavin cofactors are said to compete for the title of master 
of versatility. Flavin-dependent reactions include dehydrogenation, oxidation, 
monooxygenation, halogenation, reduction of disulfide and other types of bonds, and light-
sensing. Flavin-dependent enzymes include oxidoreductases (>90%), transferases (4.3%), 
lyases (2.8%) isomerases (1.4%) and ligases (0.4%) [4]. 
Flavins are a family of yellow-colored compounds with the basic structure of 7,8-dimethyl-
10-alkylisoalloxazine (figure 1.2), which is a fused ring structure. Flavins are derived from 
riboflavin, commonly known as vitamin B2 [5]. Flavoproteins catalyze oxidation-reduction 
reactions. In most flavoproteins flavin is found in the form as flavin adenine dinucleotide 
a) b) 
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(FAD), or flavin mononucleotide (FMN), (figure 1.2). The isoalloxazine ring can undergo 
reversible reduction by accepting either one or two electrons, (figure 1.3).  
 
Figure 1.2: Structure of flavins: Structure of riboflavin (RF), flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN)  
 
Figure 1.3: Flavin has three reduction states: Fully oxidized semiquionone form and fully reduced. Flavin can 
accept either one or two electrons and can be used in a range of reactions. The R-group differs depending on the 
type of flavin. Taken from Biochemistry dictionary, Gonzaga University [6]. 
 
The three redox states are: oxidized, one-electron reduced (semiquionone) and two-electron 
reduced. The three reduction states differ in color because of the conjugated bonds in the ring 
system. The fully oxidized form is yellow with absorption peaks at 445, 375, 265 and 220 nm. 
The semiquionone form can exist in either a neutral blue form or an anionic red form with a 
pKa of 8.5 [5]. The blue and red forms have absorption maxima at 500-600 nm and 370-400 
nm respectively. The semiquionone form has a low stability in aqueous solution and will be 
protonated, followed by reduction to the fully reduced form. The fully reduced form is 
colorless with absorption maximum near 360 nm [7].  
Riboflavin 
(RF) 
FAD 
FMN 
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Flavin has the potential to transfer single electrons, hydrogen atoms and hydride ions making 
it more versatile than other redox cofactors. Other redox cofactors usually catalyze either one- 
or two-electron transfer processes exclusively. Flavoenzymes are therefore important 
mediators between one- and two-electron processes [5, 7]. 
In flavoproteins the flavin is tightly associated with the peptide, compared to NAD/NADP 
(nicotinamide adenine dinucleotide (phosphate)). The standard reduction potential of a flavin 
nucleotide depends on the protein with which it is associated and can be in the range from 
approximately -400 mV to +60 mV for the flavin. This is caused by local interactions with the 
protein. Similarly stabilization of the semiquinone form varies among flavoprotein [7]. 
Nitric Oxide and nitrosative stress 
Nitric oxide (NO) or nitrogen monoxide is diatomic radical gas produced by enzymatic and 
non-enzymatic oxidation of reduced nitrogen compounds (figure 1.4). Properly, nitric oxide 
should be written as NO to indicate the unpaired electron, but for the purposes of this thesis 
will be written as NO [8].  In order to stabilize the unpaired electron NO can react with other 
species containing an unpaired electron, or by interacting with some transition metals, in 
particular iron. 
  
Figure 1.4: Nitric oxide: The structure of nitric oxide consists of a nitrogen atom and an oxygen atom with an 
unpaired electron. 
NO acts as a signaling molecule in a range of processes in the human body including the 
nervous system and as a regulator of blood pressure and blood flow to different organs at 
nanomolar concentrations [8]. Today, other gases acting as signal molecules have been 
discovered (e.g. ethylene regulating ripening of fruit) but the discovery that such a structurally 
simple free radical could act as a signal molecule resulted in a major paradigm shift in the 
field of cell signaling [9]. In fact Furchgoff, Ignarro and Murad were awarded the Nobel Prize 
in Physiology or Medicine in 1998 for the discovery of nitric oxide as a signaling molecule 
[10]. In mammals nitric oxide is generated by nitric oxide synthases (NOS) and disruption of 
N=O
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NO signaling is linked to hypertension, neurodegeneration, stroke and heart disease [11]. 
In addition nitric oxide plays a role in cancer, both as a signal molecule and as a toxin [12]. 
At higher (micromolar) concentrations exogenous NO also demonstrates a broad range of 
cellular toxicities termed “nitrosative stress”. Some of these toxicities are due to NO directly, 
but it seems that NO serves as a precursor for a range of reactive nitrogen species (RNS) such 
as dinitrogen trioxide (N2O3), nitrogen dioxide (NO2
*
) and peroxynitrite (ONOO
–
). 
The cytotoxic effects of NO are utilized by our immune system and so protection from NO is 
important for virulence of certain pathogens [13]. FHbs are found in various pathogens and 
protect against nitrosative stress by conversion of nitric oxide to nitrate (NO3
–
).  
In addition FHb can be used to study NO biology by heterologous expression in plants [14, 
15] and mammalian cells [16]. E. coli FHb have been shown to be active in mammalian cells.  
In addition FHb blocked the growth suppressing effects of exogenous and endogenous NO, 
and was able to blunt certain NO-dependent signaling pathways [16].  
 
Flavohemoglobin (FHb)  
1.1.3 Introduction 
FHb is flavoheme enzyme containing both a flavin and a heme cofactor (figure 1.1 and 1.2) 
Several FHbs have been characterized to date [17-24] and are found in bacteria, fungi and 
protozoa. The E. Coli FHb, hmp is the most studied. The protein is a unique combination of 
an N-terminal globin domain and a C-terminal oxidoreductase domain (figure 1.5). The 
globin domain contains heme cofactor while a FAD cofactor is found in the oxidoreductase 
domain. FHb is an NO-dioxygenase and catalyzes the dioxygenation of NO by oxidizing 
NAD(P)H yielding nitrate (NO3
-
) (Scheme I). Dioxygenases incorporate both oxygen atoms 
from an oxygen molecule (O2) into the substrate, in contrast to monooxygenases which 
introduce a hydroxyl group with water as a byproduct. 
Scheme (I): 2NO + 2O2 + NAD(P)H  2NO3
-
 + NAD(P)
+
 + H
+
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Figure 1.5: Heart shaped structure of E. coli FHb: The N-terminal globin domain is shown in red, the 
reductase domain is divided into a NAD-binding domain, shown in green and a FAD-binding domain shown in 
blue. Taken from Ilari et al. J. Biol. Chem. 2002 [25] 
 
 
Figure 1.6: Classical globin fold. The classical globin fold (illustrated by myoglobin) consists of 6 helices with 
segments from A to H. A heme molecule is found in a hydrophobic pocket within the molecule, protected from 
solution. Taken from Garrett & Grisham, Biochemistry Third edition  [26] 
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The Globin domain 
All globin domains are structurally related to vertebrate hemoglobins (Hbs) and myoglobins 
(Mbs), with two types of globin folds, classical (3/3) and truncated (2/2). The classical globin 
fold consists of six helices consisting of eight helical segments from A to H (figure 1.6). The 
heme is found in a hydrophobic pocket and is five-coordinated with the iron ion ligated to the 
proximal histidine (His(F8)). In addition a conserved phenylalanine (Phe(CD1)) appears to be 
necessary to keep the heme in correct orientation within the pocket. Apart from His(F8) and 
Phe(CD1) a wide array of amino acid residues can be found within the heme pocket. [27] 
The globin domain of FHb (5-140 aa) is a classical globin fold with an unusually long H-
helix and the D-helix is substituted by a large loop region. The heme pocket geometry shows 
little resemblance to that found in vertebrate Hbs and Mbs, apart from the conserved residues 
Phe(CD1) and His(F8). 
The architecture of distal heme pocket is found unusual with Leu57(E11) isopropyl side chain 
closest to the heme (figure 1.7). The sidechains of Tyr29(B10) and Gln53(E7) were proposed 
to be involved in heme iron ligand stabilization and are found over 5 Å away. It has been 
suggested that a conformational change upon ligand binding will rotate the leucine sidechain 
away for the tyrosine hydroxyl group to interact with the ligand [28]. Additional side chains 
within 5Å are Phe43(CD1), Ile61(E15) and Val98(G8), and the backbone of Gln53 that with 
Leu57 fill the first distal shell.  
The proximal heme pocket consists of a proximal histidine residue (His85(F8)) (figure 1.7). 
The histidine residue is involved in a hydrogen bonding network comprising of His85(F8), 
Tyr95(G5) and Glu135(H23) which is not found in vertebrate Hbs. The hydrogen bonds 
impart a rigid orientation of the imidazole ring of His85 with respect to the heme plane. Other 
conserved amino acids are Asn44(CD2), Leu012(G8) and Tyr124(H11) and Lys84(F15) [27] 
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Figure 1.7: Heme-binding site of ferric unligated FHb from E. coli (HMP). The Heme group shown together 
with a selection of amino acid residues located within 5 Å of the heme. Taken from Forrester & Foster, Free 
Radic. Biol. Med. 2012 [13]. 
 
The FAD- and NAD(P)H-binding domain 
The flavin binding domain (oxidoreductase) consists of two separate subdomains, a FAD-
binding domain (150-245 aa) and a NAD-binding domain (250-400 aa). The FAD-binding 
domain consists of a six-stranded antiparallel -barrel with Greek Key topology. A small -
helix is capping the -barrel at the bottom and a long loop connecting F2, F3 -sheets on 
the top. The NAD-binding domain consists of a five-stranded parallel -sheet flanked by two 
helices on one side and by a helix and a loop on the other. The two subdomains form an 
oxidoreductase module, which structurally belongs to the ferrodoxin reductase family (FNR). 
[27], 
The re-side geometry of the isoalloxazine-binding motif (ring structure of flavin) has identical 
orientation of the conserved residues Gln205, Tyr206, Ser207 and Tyr188 with respect to the 
isoalloxazine plane (figure 1.8). The conserved residues Val269 and Thr272 are also found on 
this side of the flavin. On the si-side of the flavin of E. coli Cys389, Phe390, Gly391 and 
Pro392 are found, the latter three being conserved. In R. eutropha with a bound phospholipid 
Val98 Ile61
Tyr29
Leu57
Gln53
His85
Glu135
Tyr95
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the same conserved residues are observed but with a different orientation which might be 
caused by a conformational change caused by lipid binding (figure 1.7) [27]. 
The conserved residues in the flavin binding domain correspond to the following residues 
found in ferrodoxin reductases: Phe390, Gly270, Glu388, Thr272, Pro273, Gly186, Gln187, 
Tyr188, and Ser232. The ferrodoxin reductases are flavin binding proteins highly specialized 
in electron transfer from NADH to a flavin moiety and to a high-redox potential electron 
acceptor [27]. 
 
Figure 1.8: FAD binding site of FHb from, R. eutropha and E. coli. The FAD-binding site of R. eutropha 
(left) and E. coli (right) shown together with a selection of amino acid residues located within 5 Å. Both sides of 
the isoalloxazine ring are shown with the re-side on top and si-side on bottom. Taken from Bonamore & Boffi 
IUBMB Life, 2008 [27]. 
1.1.4 Catalytic mechanism 
Two mechanisms have been postulated for the dioxygenation of NO: a “dioxygenation” 
mechanism and a “nitrosylation” mechanism. The first step in the dioxygenation mechanism 
involves O2 binding to ferrous (Fe
2+
) heme, while NO binds first in the nitrosylation 
mechanism (figure 1.9) [13]. Both mechanisms will result in generation of NO3
–
 and 
oxidation of heme to the ferric state (Scheme II). Regeneration of ferrous heme is proposed to 
involve an initial two-electron reduction of FAD by hydride transfer from NAD(P)H. 
Reduced FAD then passes a single electron to the heme and ferrous heme is generated with 
FAD in the semiquinone state (FADSQ). NO dioxygenation may then proceed and FADSQ can 
transfer the second electron to the ferric heme.  
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Scheme (II): NO + O2 + Fe
2+
  NO3
-
 + Fe
3+
 
Scheme (III): NAD(P)H + 2 Fe
3+
  NAD(P)+ + 2 Fe2+ 
  
Figure 1.9: Reaction scheme for FHb. The dioxygenation mechanism (left) with O1 binding first, followed by 
NO. The nitrosylation mechanism involves NO binding first (right) and regeneration of ferrous heme is 
performed by NAD(P)H (middle). 
The first step in the dioxygenation model starts by O2 binding to ferrous heme, which is 
axially ligated by a proximal histidine residue followed by NO binding forming a ferrous-oxy 
complex (Figure 1.10). In the next step the ferrous-oxy complex reacts with NO to form a 
transient Fe-ONOO intermediate, which is believed to undergo rapid isomerization and 
release of nitrate. 
 
Figure 1.10: Dioxygenation mechanism for FHb. The dioxygenation mechanism starts with O2 binding to 
ferrous (Fe
2+
) heme. The ferrous oxy-complex is stabilized by Tyr29. Nitric oxide reacts with the complex and a 
transient Fe-ONOO intermediate is formed. Spontaneous isomerization follows with a release of nitrate. 
Ferric (Fe
3+
) is reduced. Taken from Forrester & Foster. Free Radic. Biol. Med. 2012 [13]. 
Fe2+
Fe3+
Fe2+-O2 Fe2+-NO
NOO2
½NAD(P)H
½NAD(P)+
O2
NO3
-NO3
-
NO
Reduction
of heme
NitrosylationDioxygenation
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The nitrosylation model starts with NO binding to form a ferrous nitrosyl species. An electron 
transfer from heme would generate a ferric-nitroxyl equivalent, which in turn would react 
with O2 to form NO3
–
. 
Both mechanism share the “push-and-pull” mechanism in which a proximal imidazole 
(His85) imparts an electron rich character to Fe
2+
 heme which allows electron transfer to 
either O2 or NO2 
Research supporting the nitrosylation mechanism is the observation of a higher affinity of 
ferrous FHb for NO than O2 under conditions where the remaining substrate is at saturating 
conditions. The KM values are 0.28 M for NO and 100 M for O2. In addition deoxygenated 
ferrous-nitrosyl FHb undergoes rapid generation of NO3
–
 upon exposure to even micromolar 
concentrations of O2. Arguing for the dioxygenation mechanism is that mutation of Tyr29 to 
Phe impairs both O2-binding and catalysis with only marginal effects on NO affinity. [13] 
For the dioxygenation mechanism a highly conserved Tyr29 has been postulated to stabilize 
the O2-binding, but has been found over 5 Å from the heme in crystal structures for E. coli. 
Recently a computer simulation with E. coli FHb by Ferreira et al. reveals that stabilization of 
the ferrous-oxy complex is by H-bonding with Tyr29 mediated by water [29]. 
NO reductase-activity 
In addition to NO dioxygenase activity FHb also has the ability to reduce NO to N2O under 
anaerobic conditions (Scheme IV). It operates at approximately 1% the rate of aerobic 
dioxygenation. The physiological role of FHb’s NO reduction ability remains unclear, and it’s 
possible this function is overshadowed by other enzymes performing NO reduction in most 
bacteria [13].  
Scheme (IV): 2NO + 2H
+
 + 2Fe
2+
  N2O + H2O + 2Fe
3+
  
Mühlig et al. conducted a recent knockout study of Salmonella Typhimurium, a serovar (sub-
species) of Salmonella enterica. The bacterium mainly deploys three enzymes to detoxify 
NO: FHb (HmpA), flavorubredoxin (NorV) and the periplasmic cytochrome c nitrite 
reductase (NrfA) [30]. Experiments were performed in LB-medium mimicking conditions 
during fermentation of raw sausages. NaNO2 salt is used for fermentation and exerts 
nitrosative stress. The FHb knockout showed decreased growth compared to the wild type and 
12 
 
the other knockout mutants under both high and low O2 concentrations. This study indicates 
that NO reductase activity may be important for some systems. 
1.1.5 Other studies 
Several knockout studies of FHbs in different organisms have been performed and shown NO 
hypersensitivity, as well as decreased virulence/pathogenicity. Forrester & Foster have 
comprised a list of knockout studies [13]. Studies of Bacillus subtilis (a relative to B. cereus) 
show NO hypersensitivity after knock out of FHb [13], in addition to poor long term survival 
under anaerobic conditions in the presence of nitrate [31], 
As mentioned it has been proposed that FHb was generated as a fusion of genes. Studies show 
that it is necessary that the two domains are in a single polypeptide to function properly. 
Individual expression of the two domains fails to complement FHb deletion in vivo [13]. 
Kaur, et al. 2002 made a chimeric protein by fusing cDNA encoding the single domain 
Vitreoscilla hemoglobin with the C-terminal reductase domain from A. eutrophus FHb. This 
chimeric protein had NO dioxygenase activity and was able to rescue NO-sensitivity in FHb-
null E. coli. It is therefore interesting that there are bacteria, like Mycobacterium tuberculosis, 
that deploy a single globin domain (truncated hemoglobin) to protect against nitrosative 
stress. These proteins have an NO-consumption rate that are a magnitude slower than FHb 
[13].  
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Aims of the master project 
As described earlier FHbs are important in protection against nitrosative stress. Nitric oxide is 
utilized by the immune system against pathogens and knockout mutants exhibit NO 
hypersensitivity, and for pathogenic species, less virulence. FHbs are not found in higher 
eukaryotes and is thus a promising therapeutic target. In addition FHb could be used as tool to 
study NO signaling in e.g. mammals. 
Although FHb proteins from several bacterial relatives have been characterized, only a couple 
of structures from different organisms have been obtained without either a phospholipid 
bound (as in R eutropha [17]) or imidazole antibiotics [24, 25]. An additional crystal structure 
of FHb could contribute to our understanding of the catalytic mechanism, as only two 
structures of the heme pocket without ligands have been obtained. 
 
This master thesis is focuses on three main aims for the study of FHb from B. cereus. 
1. Develop a purification protocol for FHb 
Express protein using a host organism, develop a suitable purification protocol and 
purify sufficient amounts of protein for further analysis. 
2. Determine the X-ray crystal structure of FHb 
Screen for crystallization conditions of FHb and determine the structure of the 
protein using X-ray crystallography. 
3. Biochemical characterization 
Use spectroscopic techniques to investigate the properties of FHb. 
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2 Material and methods 
Molecular biology methods 
The gene for the protein to be investigated was purchased from GenScript, precloned into 
pEt22b(+) cloning vector with the restriction enzymes XbaI and BamHI (see Appendix 4). 
2.1.1 Transformation of recombinant vector into competent cells 
Transformation is a process in which exogenous genetic material is introduced into competent 
bacterial cells. The genetic material is taken up directly through the membrane, incorporated 
into host DNA and expressed. Recombinant plasmid pET22b(+) was purchased from 
GenScript and transformed into BL21(DE3) E. coli cells (Invitrogen). 
The purchased plasmid was diluted with Milli-Q water to a concentration of 50 ng/L for 
transformation. After thawing the E. coli cells on ice, 1-3 L plasmid solution was added to 
10 l cells.  The cells were kept on ice for 5 minutes, and then incubated at 42C for 
45 seconds before being returned to the ice for 2 minutes. 125 L LB medium was added to 
the cells and shaken at 37C for an hour at 225-250 rpm (Incubator Shaker Series 25, New 
Brunswick Scientific). The transformation reactions were plated on LB-plates with 
100 g/mL ampicillin and left over night at 37C. The LB-plates were inspected for growth of 
colonies the next day. Two control reactions were used, positive control with 1 l control 
plasmid (for ampicillin resistance) and a negative control without plasmid.  
2.1.2 Making bacterial freeze stocks 
Bacterial stocks are made for long term storage of plasmids within an appropriate host. 
Glycerol stocks can be stored for several years. An over-night culture of 5 mL LB-medium 
(100 g/mL Amp) was inoculated and incubated over night at 30C in a shaker at 225-
250 rpm (Incubator Shaker Series 25, New Brunswick Scientific). After growth is observed, 
200 L 60 % glycerol solution is added to 800 L of the overnight culture. Finally the stock is 
frozen with liquid nitrogen and stored at –80C 
15 
 
To recover bacteria from the stocks, only a tiny part of the still frozen stock is streaked on 
LB-agar plates (100 g/mL Amp). The plates are grown overnight at 37C until colonies are 
visible. 
Protein methods 
2.1.3 Over-expression of recombinant gene in E. coli cells 
Bacteria from freeze stocks were grown on LB-agar plates (100 g/mL Amp) overnight at 
37C. Immediately after colonies were observed the plates were removed and stored in room 
temperature (20C) for slow growth. An over-night culture of 200 mL LB-medium 
(100 g/mL Amp) was inoculated and incubated over night at 30C in a shaker at 225-
250 rpm. The over-night culture was diluted by transferring 50 mL to 1 L TB-medium 
(100 g/mL Amp) (See Appendix 3) and incubated at 30C in a shaker at 225-250 rpm. 
After about 8 hours the culture was diluted 20 times into new flasks with 1 L TB-medium 
(100 g/ml Amp) each, usually 12 flasks.  
The cells were grown until OD600 reached 0.8 and, the heme precursor, -aminolevulinic acid 
(ALA) was added to a concentration of 0.2 M and expression was induced with 1.0 mL 
1 M IPTG after cooling the medium on ice to 20C or less. The culture was incubated 
overnight at 20C at 225-250 rpm. Bacteria were harvested by centrifugation at 6500 g the 
following day.  
2.1.4 Protein purification 
Lysis of bacterial cells 
For cell lysis an AB X-press® system [32] was used. Frozen bacterial cells were lysed by 
high pressure and mechanical stress. Frozen bacterial cells were added to a precooled X-Press 
column (-20C) and mounted on a stand. Using mechanical pressure the bacterial cells were 
pushed through a tiny hole of the X-press column repeatedly, which breaks the cells, freeing 
its contents. 
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Precipitation of DNA 
The crushed cells were then dissolved in Buffer A (Appendix 3) containing ½ protease 
inhibitor pill (cOmplete ULTRA Tablets, Mini, EasyPack by Roche) at 4C and centrifuged at 
48 000 g for 1 hour at 4C to remove cell debris. A 10% streptomycin sulfate solution 
(pH 7.5) was added slowly, drop by drop to the supernatant, to a final concentration of 2 % 
streptomycin sulfate in order to precipitate DNA. The solution was then centrifuged at 
48 000 g for 30 minutes to remove the precipitated DNA. The supernatant was used for 
ammonium sulfate precipitation. 
Ammonium sulfate precipitation 
Ammonium sulfate ((NH4)2SO4) precipitation is a method to purify proteins, as different 
proteins precipitate at different concentrations of ammonium sulfate. After addition of 
ammonium sulfate the precipitated proteins are separated from proteins in solution by 
centrifugation. When the process is repeated with sequentially higher ammonium sulfate 
concentrations the precipitates/pellets are essentially different fractions containing different 
proteins. The process can be optimized by varying salt concentration to remove proteins that 
precipitate before and after the protein of interest. 
A procedure of adding ammonium sulfate in 3 steps was used, where each step was followed 
by centrifugation at 48 000 g. First 0.21 g/mL salt was added and spun, followed by 0.09 
g/mL (30 g/mL in total). This was repeated until the ammonium sulfate concentration was 
0.43 g/mL yielding three pellets. 
Chromatography 
All chromatography procedures were performed using the Äkta Purifier-system from 
GE Healthcare. This Äkta system can measure the absorbance and conductivity of the protein 
samples. Absorbance is measured in order to observe and separate proteins from each other 
while conductivity is an indicator of the salt content. The Äkta system can be operated 
manually or automatically. 
Most of the columns used were packed by the group, column material and empty columns 
have been supplied by GE healthcare. During elution absorbance was measured at 280, 400 
and 450 nm. All proteins absorb light at 280 nm as the aromatic amino acids (tyrosine and 
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tryptophan, and to a less degree phenylalanine) absorb light at this wavelength. Heme has a 
Soret peak (absorption maximum) at approximately 400 nm, and flavins have a maximum at 
450 nm. Fractions with high absorbance at 400 nm and 450 nm were collected in the 
following chromatography procedures. 
The following columns were used 
XK 26 column with 70 mL Sephadex 25 (packed by the group) 
XK 26 column with 70 mL HPQ Sepharose (packed by the group) 
XK 16 column with 120 mL Superdex 200 (packed by the group) 
Prepacked Superdex 200 10/300 GL (GE Healthcare) 
HiTrap Desalting column, 5 mL (GE Healthcare) 
Desalting 
The precipitated protein was resolved in Buffer A, and a desalting column (Sephadex 25) was 
used in order to lower the salt concentration of the sample by separating the low molecular 
weight components (salt) and the high molecular weight molecules (proteins). A low salt 
concentration is essential for a successful ion-exchange chromatography, since salt will 
compete with protein for binding to the anion-exchange columns. Buffer A was used; the 
Äkta system was operated manually by starting to collect the protein fraction when an 
increase in absorbance at 400 nm was observed and stopping the collection when absorbance 
at 400 nm decreased and before the conductivity rose. 
Anion-exchange chromatography 
Anion-exchange is a method for separating proteins by the charges on the protein surface. 
Proteins will bind to the column by electrostatic interactions. The charges on the protein 
surface depend on the pH as some of the amino acid residues will get protonated or 
deprotonated affecting the total charge. During anion exchange chromatography proteins with 
negative charges on the protein surface bind to the column material, the column material itself 
is positively charged. Protein elution is performed by increasing the salt concentration as the 
negative ions of the salt will compete with the proteins for binding. 
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Different salt gradients can be used for elution, including simple linear gradients and step-
gradients. A slack gradient will result in higher resolution, separating proteins of similar 
charge. The step gradients used consist of a series of linear gradients with “plateaus” (flat 
segments with no increase in salt concentration) to elute proteins that bind slightly stronger or 
weaker than the protein of interest. 
For ion-exchange a XK 26 column with 70 mL HPQ-Sepharose was used with buffer A and 
buffer B. The procedure was optimized for the protein so that other proteins that bind poorly 
will elute early and proteins that bind tighter will be washed out by increasing the salt 
concentration. Both linear and step gradients were used for purification, more details are 
found in the Results-section. 
Gel-filtration chromatography 
Gel filtration chromatography is a type of size exclusion chromatography with an aqueous 
mobile phase and a stationary phase. Gel filtration separates protein based on protein size. 
The gel material consists of beads with pores that allow smaller molecules access to a larger 
volume than larger molecules. Larger molecules will have less volume available and will pass 
through the column quicker than smaller molecules. Protein samples from anion-exchange 
chromatography procedure were purified by gel filtration chromatography. 200 l of 
concentrated protein was loaded on a Superdex 200 column (XK16) run with Buffer C 
separating the proteins with respect to size. The fractions with high 400 and 450 nm values 
were collected. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Samples from different purification steps can be analyzed by sodium dodecyl sulfate (SDS) 
polyacrylamide gel electrophoresis (SDS-PAGE). SDS is an anionic detergent that binds to 
proteins, causing it to linearize and become negatively charged. The charge of the protein 
becomes proportional to the mass, and proteins are separated by mass on the gel by an electric 
field. 
For analysis protein samples were mixed with NuPAGE® LDS sample buffer (Life 
technologies) with a volume of a quarter of the sample volume and incubated at 96C for 5 
minutes, vortexed and applied to a 10- or 15-well NuPage 4-12% Bis-Tris gel 
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(Life technologies). The gel was run for 35 minutes at 200 V with NuPage® MOPS SDS 
Running Buffer (Life technologies). 10 L of Novex® Sharp Pre-Stained Protein Standards 
(Invitrogen) ladder was used. 
After gel electrophoresis the gel was either stained with Brilliant Blue R250 (Sigma) or 
InstantBlue (Expedeon). For Brilliant Blue staining the gel was soaked in 0.1% Coomassie 
Brilliant Blue R250, 40% EtOH (ethanol), 10% HAc (Acetic acid) and heated for 20 seconds 
in a microwave before being transferred into destaining solution and destained overnight. 
InstantBlue Coomassie staining was performed by leaving the gel in solution until bands were 
visible, ca. 15 minutes. 
Ultra filtration 
Ultra filtration was used to concentrate samples from ion-exchange and size exclusion 
chromatography for crystallization. Amicon Ultra 30 K-15 (or -4) or Centricon Plus 30 K-70 
tubes were used as describes by the manufacturer (Millipore). A cutoff of 30 kDa was used as 
FHb has a molecular weight of 48.8 kDa. A typical set up for the Amicon Ultra 30 K-15 was 
4750 g at 4C with a fixed rotor angle for 18 minutes. 
2.1.5 Protein crystallization 
SDS-PAGE and UV-vis was used to analyze the purity and indicate cofactor content of the 
samples. Several crystallization trials were performed on pure protein samples. Crystallization 
screening was performed using either an Oryx6- (Douglas Inst. Ltd.) or Mosquito robot 
(TTP Labtech) offered by the Structural biology Core Facility at Rikshospitalet Oslo 
University Hospital (Bjørn Dalhus). Both robots prepared 96 sitting drop experiments in 
crystal trays, with the Mosquito being considerably faster, and needing less protein, but with a 
smaller drop size (0.2 L in contrast to 0.8 L for the Oryx6 robot). The Oryx6- and 
Mosquito robot prepared drops in room temperature and at 4C, respectively. The crystal 
trays were stored either in room temperature or at 4C. The trays were monitored with a light 
microscope immediately after drop preparation, in order to check for crystal growth, and 
regularly for the next weeks and (less frequently) months. 
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Optimization of crystal conditions was performed manually with 2 L sitting drops at room 
temperature under a light microscope (SMZ168 LED, Motic) with a 1:1 ratio between the 
protein solution and crystallization solution.  
2.1.6 Reconstitution of heme and FAD 
Reconstitution of heme-deficient FHb with heme was performed under reducing conditions 
(10 mM DTT) and with the presence of catalase as described by Gardner, NO dioxygenase 
assays [33], using degassed buffer instead of N2-sparged buffer and in a smaller scale. FHb 
(0.5 to 0.75 mM) was prepared in 400 l Buffer D (3000 U of catalase) and 20 mM hemin 
(dissolved in dimethyl sulfoxide) was added slowly to a final concentration equal to the 
concentration of FHb. Dithionite (2 mg freshly dissolved in water) was added after 
15 minutes of incubation at 20C, followed by 60 minutes of incubation at 37C. The solution 
was then run on a 5 ml HiTrap Desalting column (Pharmacia) with buffer D and a Superdex-
200 column to separate the target protein from heme, catalase and reductants. 
Initial testing was performed with 100 M FHb in 100 L buffer. The same procedure was 
also tested with FAD (dissolved in MilliQ-H2O) instead of heme, and by addition of both 
heme and FAD to the same solution, e.g. 100 M heme, 100 M FAD and 100 M FHb in 
100 L buffer. 
Protein Assays 
2.1.7 Ultraviolet-visible spectroscopy 
UV-vis spectroscopy was performed to determine protein concentration and indicate heme 
and FAD content of FHb.  
Protein concentration of FHb was determined using Agilent 8453 Diode array 
spectrophotometer. Protein samples were diluted until the absorbance measured was below 
1.0. The absorbance at 405 nm was measured and protein concentration was calculated using 
the extinction coefficient 88 600 M
–1
cm
–1 
[34]. Indication of heme content was measured by 
comparing absorbance at 280 nm and 405 nm. All proteins absorb at 280 nm and heme has a 
Soret peak at 400 nm. 
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2.1.8 Assay for Heme content 
A small pinch of dithionite (2 mg) was dissolved in MilliQ-H2O. A 300 L sample of FHb 
containing 1.2 to 12 nmol of heme was added to 300 L of 4.4 M pyridine/0.2 M NaOH 
solution and mixed. Absorbance was measured at 556 nm and 539 nm before and 
immediately after adding the dithionite solution and gently mixing the sample in a cuvette. 
Potassium ferricyanide (100 mM) was then added stepwise at 3-L aliquots to the cuvette and 
absorbance at 556 nm and 539 nm were recorded. Heme concentrations in the sample was 
calculated from the absorbance differences of the reduced minus oxidized heme at 556 nm 
and 539 nm. M heme is given by the following formula: M heme = 46.7 (A556 – A539) 
[35, 36] 
2.1.9 FAD analysis 
10 to 20 nmol protein was dissolved in 1 ml Buffer C and boiled for 3 minutes. The solution 
was then centrifuged at 20 000 g to remove the denatured protein. 0.8 ml of the supernatant 
volume was added to 1.2 ml Buffer A and FAD-content was measured by Absorbance at 450 
nm with an extinction coefficient of 11 300 M
-1
cm
-1
. 
2.1.10 Bradford protein assay 
Protein concentration was measured using a Quick Start Bradford protein assay (Biorad) and 
Modified Lowry protein assay, explained under [37].  
Approximate protein concentrations were obtained through UV-vis spectroscopy by 
measuring absorbance at 280- and 405 nm with extinction coefficients of 44 900 M
–1
cm
–1
 
(calculated with ProtParam [38]) and 88 600 M
–1
cm
–1 
[34], respectively. 
The linear range of the Bradford assay with bovine serum albumin (BSA) is from 125 g/mL 
to 1000 g/mL. Protein concentration is determined by making a standard curve (e.g. linear 
regression) with a range of BSA concentrations. Concentration of the target protein is then 
calculated from absorbance of the sample by utilizing the standard curve.  
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The 1 mL assay with disposable cuvettes was performed to determine protein concentration. 
A prediluted BSA standard was used (GBiosciences) with the following concentrations: 
100 g/mL, 200 g/mL, 300 g/mL 500 g/mL 800 g/mL and 1000 g/mL. In order to 
determine protein concentration, 1 mL of Coomassie Brilliant Blue G-250 dye (Biorad) was 
added to 20 L of each standard and unknown sample solution and mixed. The samples were 
incubated for 5 minutes at room temperature and absorbance were measured at 595 nm and 
compared to the BSA standard curve. 
2.1.11 Modified Lowry protein assay 
Modified Lowry assay was used for protein determination. Similarly to the Bradford assay, 
protein concentration is calculated from a standard curve. The same prediluted BSA standard 
for the Bradford assay is used for this method. The BSA standard is not linear within the 
range, and a point-to-point curve is preferable to a linear fit, if plotted by hand, according to 
the manufacturer [39]. 
1X Folin-Ciocalteu Reagent (Thermo) was prepared by diluting with MilliQ-water. BSA was 
used as a standard from 100 g/mL to 1000 g/mL (GBiosciences). 0.2 mL of each standard 
and unknown sample replicates were prepared. At 15 second intervals 1 mL of Modified 
Lowry Reagent (1x) (Thermo) is added to each tube, mixed and incubated at room 
temperature for 10 minutes. 100 L of 1X Folin-Ciocalteu Reagent was added after exactly 
10 minutes, maintaining the 15-second interval between tubes. Test-tubes were covered and 
incubated for 30 minutes at room temperature. Absorbance was measured at 750 nm and 
concentrations were calculated from the BSA standard. The spectrophotometer was blanked 
with a sample of water. “Blank samples” without protein, were prepared as protein samples, 
and measured at 750 nm and subtracted from each standard and unknown protein sample. 
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3 Results and discussion 
Expression 
Plasmids ordered from (GenScript Inc.) were successfully transformed into competent 
BL21(DE3) cells. FHb was expressed and SDS-PAGE was used to identify over-expressed 
proteins which showed over-expression after induction with IPTG (Figure 3.1a). A total 
number of three over-expressions were performed. Because of low cofactor content of the 
pure protein, discussed later (see UV-vis and heme assay), the amount of ALA was increased 
from 0.2 M to 0.25 M and 0.3 M riboflavin was added (Figure 3.1b) for the last run. 
 
Figure 3.1: SDS-PAGE analysis of protein expression: Coomassie stained polyacrylamide gel showing 
expression of proteins before and after induction with IPTG. a) Over-expression with 0.2 M ALA, b) Over-
expression with 0.25 M ALA and 0.3 M riboflavin. Cells are either lysed or not, as indicated on the figure. 
Lysed cells show proteins in the cell cytoplasm and indicate that the protein is soluble. Each sample was applied 
twice at different concentrations the second (right) are diluted 2-fold. 
Both gels have clear bands between 40 kDa and 50 kDa, which indicate that FHb is 
overexpressed (MW 44.8 kDa). A band of similar size is present even before induction. This 
might be due to another protein of similar size or some expression of FHb even before 
induction. The FHb band is clearly present after cell lysis, which indicates that the protein is 
successfully overexpressed and soluble inside the cells. After overexpression a yield of 
150 g bacteria is obtained for 12 L of TB-medium or 12.5 g per L of cell culture. 
 
a)             b) 
FHb 
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Purification 
In order to obtain pure protein samples for crystallization a 3-step purification procedure was 
established and optimized consisting of ammonium sulfate precipitation, anion exchange 
chromatography and gel filtration.  
3.1.1 Ammonium Sulfate precipitation 
The first step of purification is ammonium sulfate precipitation; figure 3.2 shows an SDS-
PAGE analysis of this step. A band of expected size (45 kDa) is present in all of the 
pellets/fractions but in higher concentration in the last two (0.30 g/ml and 0.43 g/ml). There is 
no band at 45 kDa in the supernatant in figure 3.2 indicating that the protein has precipitated 
and is found in the pellets. Holo-FHb contains both heme and FAD and has an orange color. 
FHbs from other organisms have shown that heme and FAD content varies and both cofactors 
can be lost during purification, resulting in substoichiometric heme and FAD [33]. The last 
precipitation had the strongest reddish color (figure 3.3) indicating a higher content of heme. 
Further purification was performed with the pellets precipitated with 0.30 g/mL and 
0.43 g/mL ammonium sulfate either separately or by combining the two (mix-fraction). 
 
Figure 3.2: SDS-PAGE analysis of ammonium sulfate precipitation: The gel shows protein samples after 
resuspension of pellets from ammonium sulfate precipitation. Precipitation is performed in three steps with 
0.21 g/mL, 0.30 g/mL and 0.43 g/mL ammonium sulfate (see Methods). Supernatant after addition of 0.43 g/mL 
and centrifugation is also shown. Each sample is applied to the gel twice with the first (left) with 2-times more 
protein. 
FHb 
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Figure 3.3: Picture of protein sample after resuspension of the pellets 
obtained after ammonium sulfate precipitation. The 0.43 g/mL sample has a 
stronger reddish color than the 0.30 g/mL sample. 
 
 
 
3.1.2 Anion Exchange chromatography 
The second step of purification is anion exchange chromatography (IEX). Optimization of the 
purification procedure was mainly performed on this step. An overview of the different 
programs/gradients used is found in table 3.1. A small scale test was performed (figure 3.4) 
with a gradient from 0-100 % salt at pH 7.5, with the 0.43 g/mL and 0.30 g/mL fractions from 
ammonium sulfate precipitation. Both fractions were tested as the fractions had different 
color, indicating a difference in cofactor content and with other proteins present two different 
IEX-procedures might be needed.  
A peak with absorption at 400 nm is observed at a salt gradient of 20 % for both pellets. The 
peak is distinctly larger for the 0.43 g/mL and with a lower 280 nm peak. Indicating less 
protein but more heme cofactor as is expected by the color of the sample (Figure 3.3). The 
0.43 g/mL fraction also contains more of other proteins and the “shoulders” are larger, and 
possibly less pure than the 0.30 g/mL sample. The 400 nm peaks were collected and analyzed 
by SDS-PAGE (figure 3.5) for assessing degree of purity and to aid optimization. The SDS-
PAGE shows a band at the expected size for both ammonium sulfate fractions. Some 
impurities are observed but the protein is already quite pure after this step. 
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a) 
 
b) 
 
Figure 3.4: Small scale anion exchange chromatogram 
Chromatogram from small scale IEX with a salt gradient of 0-100%. The black line, red line and blue line 
correspond to 400 nm, 280 nm and 450 nm, respectively. The pink line is measured conductivity. Protein with 
absorption at 400 nm is collected (indicated in the figure). a) Chromatogram for 0.43 g/mL pellet, 
b) Chromatogram for 0.30 g/mL pellet 
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Figure 3.5: SDS-PAGE analysis of small scale IEX  
The gel shows collected fraction after small scale IEX. Each sample is applied to the gel twice with the first (left) 
with 2-times more protein. 
 
Table 3.1 Overview of anion-exchange experiments performed 
Fraction Gradient type Gradient Chromatogram Gel 
0.43 g/mL  
Linear 0-100% Fig. 3.4a Fig. 3.5 and 3.10 
Linear 0-30% Fig 3.6a Fig 3.10 
Step Step1 Fig 3.6b - 
0.30 g/mL 
Linear 0-100% Fig 3.4b Fig 3.5 and 3-10 
Linear 0-50% Fig 3.7b Fig 3.10 
Step Step1* Fig 3.7a - 
Mix 
Linear 0-30% Fig. 3.9 Fig 3.10 
Step Step1* Fig. 3.8a Fig 3.10 
Step Step2** Fig. 3.8b Fig 3.10 
Overview of anion exchange experiments performed. Step gradients consist of 6 steps of 2 column volumes 
(CV) each, unless specified otherwise. After the step gradient the column is washed and re-equilibrated with 
5 CV and 5 CV, respectively. *Step1: 0-0%, 0-8%, 8-8%, 8-17% (8 CV), 17-17%, 17-30% 
**Step2: 0-0%, 0-12%, 12-12%, 12-20% (10 CV), 20-20%, 20-50% 
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Large scale purification 
After the initial test of anion exchange, large scale purification was performed at pH 7.5. 
SDS-PAGE analysis was performed after chromatography and a selection of SDS-gels are 
shown in figure 3.10. 
 
The 0.43 g/mL fraction 
As the 0.43 g/mL-fraction was expected to have the heme cofactor this was purified first. 
Based on the chromatogram from the small scale tests the gradient range was reduced to 
obtain a better separation of FHb from the other proteins. This resulted in a linear gradient for 
large scale purification from 0-30% salt at pH 7.5 (figure 3.6a) and was the main purification 
method for this fraction/pellet. During purification of the 0.30 g/mL fraction a step gradient 
was tested, (Step1 found in table 3.1). The Step1 gradient was also tested on the 0.43 g/mL 
pellet (figure 3.6b) 
The chromatogram for purification with a linear gradient (Figure 3.6a) has a similar peak as 
during initial testing but the “shoulders” are smaller. The protein has a high degree of purity 
as seen on the SDS-gel. However it is difficult to compare the PAGE-analysis between the 
initial test and the large scale purification, although the chromatogram shows a better 
separation. The step gradient in figure 3.6b looks promising with a broader peak and better 
separation but there is still some background. pH during the step chromatography is uncertain 
but probably around 7 as there were some problems with the pH-meter at the time, which was 
discovered later. 
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a) 
 
b) 
 
Figure 3.6: Anion exchange chromatograms for 0.43 g/mL fraction  
The black line, red line and blue line correspond to 400 nm, 280 nm and 450 nm, respectively. The pink line is 
measured conductivity. Protein with absorption at 400 nm is collected as indicated in the figure. The 
chromatograms show two different gradients: a) linear gradient from 0-30% salt and b) Step1. 
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a) 
 
b) 
 
Figure 3.7: Anion exchange chromatogram for 0.30 g/mL-fractions 
The black line, red line and blue line correspond to 400 nm, 280 nm and 450 nm, respectively. The pink line is 
measured conductivity. Protein with absorption at 400 nm is collected as indicated in the figure. 
The chromatograms show two different gradients: a) Step1 and b) a linear gradient from 0-50% salt. 
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The 0.30 g/mL fraction 
Even though the 0-30 % gradient worked for the 0.43 g/mL fraction, a step gradient was 
tested (Step1 in Table 3.1) for the 0-30 g/mL fraction to improve separation of proteins. The 
Step1 gradient is based on elution before 18% salt, as was the case during purification of 
0.43 g/mL, with a slack gradient from 8% salt to 17% salt. FHb elutes at a quite high salt 
concentration compared to this range and there were some problems with FHb eluting late 
during the program (results not shown). In response to this a simple gradient from 0-50% salt 
was used for main purification of the 0.30 g/mL fraction (figure 3.7b). From the 
chromatogram with the linear gradient the protein is expected to be quite pure, which is 
confirmed by the gel (figure 3.10). 
Mixing of ammonium sulfate -fractions 
Purification of both ammonium sulfate fractions yield high purity after anion exchange and 
mixing of the pellets was tested. The result after mixing the pellets will be called the “mix-
fraction” As the 0.43 g/mL fraction contains more heme as indicated by the color, the 
fractions could be separated in order to get protein with more cofactor for characterization and 
crystallization. However (as discussed later) the heme content varies and reconstitution after 
purification is needed anyway as crystals require a homogenous solution (either only apo- or 
holo-protein). In addition by mixing the pellets, which corresponds to removing an 
ammonium sulfate precipitation, it would be possible to simplify and “speed up” the 
purification procedure by needing fewer separate steps.  
Both the 0-30% linear gradient and the Step1 gradient were tested. In addition another step 
gradient was created (Step2, see Table 3.1). Step2 was created with expected elution between 
12% and 20% based on the observation from the Step1 gradient that the protein is eluting a bit 
late. It is worth noting that the sample from this expression had a lower heme content than 
previous runs, as the 405 nm / 280 nm ratio (discussed later) is consistently lower after 
purification and is also observed in figure 3.8. This also shows that the cofactor content can 
vary between different expression runs. An offset observed between the main 280 nm peak 
and 400 nm peak, as seen in Figure 3.8 for Step2, indicates that apo-FHb has a slightly lower 
affinity for the column. Both step gradients have two distinct flavin peaks at 450 nm within 
the main 280 nm peak. This is not observed for the other ammonium sulfate fractions. 
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a) 
 
b) 
 
Figure 3.8: Anion exchange chromatogram with step gradients for the mix fraction. 
Chromatograms for the mix fraction. The black line, red line and blue line correspond to 400 nm, 280 nm and 
450 nm, respectively. The pink line is measured conductivity. Protein with absorption at 400 nm is collected as 
indicated in the figure. The chromatograms show two different gradients: a) Step1 and b) Step2. 
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Figure 3.9: Anion exchange chromatogram with a linear gradients for mix fraction  
Chromatogram of mix fraction with a salt gradient from 0-30%. The black line, red line and blue line correspond 
to 400 nm, 280 nm and 450 nm, respectively. The pink line is measured conductivity. Protein with absorption at 
400 nm is collected as indicated in the figure. 
 
Figure 3.10: SDS-PAGE analysis of anion exchange chromatography  
The figure shows a collection of different SDS-gels, divided by white lines. The top row indicates the salt 
gradient used for purification, while the bottom row indicates the ammonium sulfate fraction. 
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The chromatograms with a linear gradient (figure 3.9) and Step2 (figure 3.8b) show a single 
peak at 280 nm and 400 nm for FHb. The Step1 (figure 3.8a) 400 nm peak is found between 
two peaks at 280 nm, it is however likely part of the first peak. 
SDS-PAGE analyses show that all methods yield a pure protein, but containing a varying 
fraction of apo-protein. For the mix Step2 seems to be the method giving the highest purity. 
The chromatograms are in agreement with this, with the Step2 showing less other protein as 
seen from the 280 nm detection curve, with Step 1 being the worst. 
Both the linear gradients with 0-30 % or 0-50% salt are good for purifying the ammonium 
sulfate fractions. Arguing for separation of the two ammonium sulfate fractions is the fact that 
the 0.43 g/mL fraction contains more heme, and it could be beneficial to purify separately in 
order to have a higher heme/protein ratio. However this ratio is not very high (discussed later) 
and heme reconstitution should be performed anyway. In order to save time mixing is 
probably better and Step2 is the best choice as the background at 280 nm is lowest for this 
method. With this procedure it might be possible to separate fractions depending on the 
amount of cofactor in the protein. According to Gardner, NO dioxygenase assays [33] 
ammonium sulfate precipitation could decrease heme content. Using another method for 
crude protein purification it might be possible to separate apo- and holo-FHb with the Step2-
gradient. 
3.1.3 Gel filtration 
The last step of purification is gel filtration. An overview of gel filtration chromatograms 
from the different anion-exchange programs are found in the appendix, as they are quite 
similar. A small contamination of another protein can be observed by a shoulder before the 
main peak (figure 3.11). The shoulder size varies, from a quarter of the size (height) and less. 
Occasionally an additional peak is observed at around 120 mL, but it never overlaps with the 
collected fraction and is always quite small (Appendix 6). SDS-PAGE analysis of the 
collected fraction shows a very pure protein. The purity increases for each purification step. 
A weak band at around 35 kDa is observed on approximately half of the gels, depending on 
the amount of sample applied, (figure 3.12). Some additional bands are observed in this 
particular instance. Protein yield after purification is around 20 mg / 30 g bacteria (8 mg 
per 1L cell culture) 
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Figure 3.11: Chromatogram from gel filtration  
Chromatogram of gel filtration. The black line, red line and blue line correspond to 400 nm, 280 nm and 450 nm, 
respectively. Protein with absorption at 400 nm is collected as indicated in the figure. 
 
Figure 3.12: SDS-PAGE analysis of protein purification: The gel shows protein samples after ammonium 
sulfate precipitation, desalting, anion exchange experiments and a gel filtration step.  
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UV-vis spectroscopy 
UV-vis spectroscopy was used to determine protein concentrations as described in the 
methods section. Calculated yield is found in table 3.2. The spectrophotometer was also used 
to give an indication of cofactor content, mainly heme. 
3.1.4 Ammonium sulfate precipitation 
Absorbance was measured after ammonium sulfate precipitation and desalting. The ratio 
between 405 nm (Soret peak) and 280 nm is found in Table 3.3. The results are from the 
expression with addition of ALA and riboflavin, and the ratio is expected to be higher for 
earlier purification experiments. When the ratio of purified protein is measured, the last 
expression with ALA and riboflavin has a lower 405 nm / 280 nm ratio, than previous 
purifications. The results show a ratio of 0.054 for the 0.30 g/mL pellet and 0.096 for the 0.43 
g/mL-pellet indicating an almost twice the heme content, which is in agreement with the color 
of the solution (figure 3.3) and chromatograms from IEX (figure 3.4-3.9). The mix fraction 
has a ratio between the two pellets which is expected. 
3.1.5 Gel filtration 
The ratio between absorbance at 405 nm and 280 nm was also recorded after gel filtration as 
an indication of the amount of FHb containing the heme cofactor (table 3.3). The ratio shows 
a rather large variation and is found to be roughly between 0.15 and 0.70. As the 405 nm / 280  
nm-ratio depends on both the initial cofactor content incorporated during the over-expression 
as well as the choice of purification procedures it is difficult to draw conclusions about the 
effect of using different gradients during IEX. The 0.43 g/mL sample has the highest ratio, 
which is expected. Similarly the 0.30 g/mL sample has a lower ratio. From table 3.3 it is clear 
that the mix-fractions have the lowest ratio. This is likely a consequence of a less successful 
over-expression with respect to cofactor incorporation. Induction and addition of cofactors 
were a bit late, and riboflavin was not dissolved properly at the time of addition. 
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Table 3.2: 405 nm / 280 nm ratio after desalt 
Ratio 0.30 g/mL 0.43 g/mL Mix1 Mix2 
OD405/OD280 0.05423 0.09648 0.08317 0.07455 
The table shows the ratio between 405 nm and 280 nm after ammonium sulfate precipitation and desalting. 
About half of the ammonium sulfate fractions were mixed before application to the desalting column, and had to 
be applied twice. The eluates are named Mix1 and Mix2. 
 
Table 3.3: 405 nm / 280 nm ratio after gel filtration 
 
(NH4)2SO4 
ALA 
M 
Riboflavin 
M 
 
Gradient 
 
Figure 
405 nm / 
280 nm 
0.43 g/mL 0.2 - Linear 0-30% 3.6 0.52-0.63 
0.43 g/mL 0.2 - Step1 3.6b 0.66 
0.30 g/mL 0.2 - Linear 0-50% 3.7b 0.37-0.38 
0.30 g/mL 0.2 - Step1 3.7a 0.44 
Mix 0.25 0.30 Linear 0-30% 3.9 0.26 
Mix 0.25 0.30 Step1 3.8a 0.16 
Apo* 0.25 0.30 Step2 3.8b 0.05 
The table shows the ratio between 405 nm and 280 nm after gel filtration with additives during over-expression, 
the ammonium sulfate fraction used, the gradient type during IEX and the applicable figure. *After IEX of a 
mix-fraction the 280 nm peak was collected in two fractions, the fraction consisting of apo-protein is shown. 
3.1.6 FHb reduction by NADPH 
UV-vis spectra of FHb after purification and after reduction by NADPH in GF-buffer (pH 7) 
under aerobic conditions were taken. After purification FHb is mainly in the ferric (Fe
3+
) 
form, with a Soret peak at 405 nm, with additional smaller peaks at 542 nm and 572 nm. After 
addition of NADPH, the Soret peak moves to 411 nm, with clear peaks at 543 nm and 578 
nm, respectively. The spectra are similar to that of flavohemoglobins from other organisms 
[18, 20-22, 34]. The reduced spectrum indicate that NADPH can reduce heme through FAD 
as an intermediate, like other FHbs and that it works as an electron donor. It would be 
interesting to see if reduction is similar with NADH.  As oxygen is present it will likely bind 
to the reduced iron of the heme group as shown by the appearance of the peaks at 543 nm and 
578 nm. A FAD peak is expected between 450 nm and 480 nm, but because of overlapping 
spectra with heme, it is difficult to observe, there is a slope change after reduction, which 
might be from FAD.  
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Figure 3.13: UV-vis spectroscopy of FHb: FHb in GF-buffer (pH = 7.5) is reduced by NADPH under aerobic 
conditions. The Black line is FHb after purification, in the oxidized state. The Red line shows FHb after 
reduction by NADPH with O2 binding. 
 
Assays 
3.1.7 Protein Concentration 
Bradford and Modified Lowry assay was performed, as described in the Methods section, in 
order to determine protein concentration of the purified FHb samples. In order to calculate 
protein concentrations of holo protein an extinction coefficient of 88.6 mM
-1
cm
-1
 for the Soret 
peak (405-406 nm) was used [34]. To indicate total concentration an extinction coefficient of 
44.81 at 280 nm was used. The extinction coefficient was calculated from the protein 
sequence with Protaparam (Expasy) [38].  
The Bradford and Modified Lowry give the total concentration of the FHb. Bovine Serum 
Albumin (GBiosciences) was used to generate the standard curves shown in figure 3.14. The 
overall shape of the Modified Lowry Assay curve does not seem to be linear in the 
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concentration range tested and so a quadratic fit was used. A linear fit was used with the 
Bradford assay. According to the manufacturer (Bio-Rad) the linear range of the assay is from 
125 g/mL to 1000 g/mL. The linear fit is calculated for this range and the standard at 
100 g/mL is not taken into consideration since it is outside the linear range. Extrapolation is 
performed for the Bradford assay, with absorbance of FHb samples  0.63 (absorbance of 1.0 
mg/mL BSA = 0.60). The calculated protein concentrations are shown in Table 3.5. 
As both protein assays were performed with the same sample concentration there is a rather 
large discrepancy between the two methods with calculated concentrations of 1.04 mg/mL 
and 0.59 mg/mL for the Bradford and Modified Lowry assay, respectively.  Both methods 
are affected by the standard used, (e.g. BSA or gamma globulin) and the color response varies 
with the proteins assayed [37, 40, 41]. In addition as extrapolation was performed for the 
Bradford assay a higher uncertainty is expected. 
Table 3.4: Fit for protein assays 
Assay Fit a b c R
2
 
Bradford Linear 0.12358 0.48642 - 0.98164 
Lowry Quadratic 0.09875 2.77648 -1.47847 0.99512 
The fit for the standard is expressed in the form: f(x) = a + bx + cx
2
. Absorbance is expressed by 
x (concentration in mg/mL) and the constants (a, b, c and d). 
a)           b) 
 
Figure 3.14: Bradford assay and Modified Lowry protein assays. Bradford assay (a) and Modified Lowry 
assay (b) was performed as described in Methods with a bovine serum albumin (BSA) standard. The squares 
represent the BSA standard with the fits shown. A linear fit is used for the Bradford Assay and a quadratic fit for 
the Modified Lowry assay. Only the squares within the box are used for fitting. 
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Table 3.5: Calculated concentrations for the Bradford assay and Modified Lowry assay 
Assay Fit /  Average 
mg/mL 
Sample 1 
mg/mL 
Sample 2 
mg/mL 
Sample 3 
mg/mL 
Bradford Linear fit 1.04 1.04 1.02 1.06 
Lowry Quadratic fit 0.59 0.62 0.59 0.56 
 
By comparing the protein concentration measured by the protein assays with absorbance of 
FHb in solution at 280 nm (measured with a UV-vis spectrophotometer) the following 
extinction coefficients were calculated, 280 = 70.36 mM
-1
/cm
-1 
and 280 = 124.02 mM
-1
/cm
-1
 
for the Bradford assay and Modified Lowry assay, respectively. There is a rather large 
difference between the two extinction coefficients, also compared to the extinction coefficient 
calculated by ProtParam (44.81 mM
-1
/cm
-1
) [38]. FAD absorbs light at 280 nm which is not 
taken into account by the ProtParam tool, so the extinction coefficient is expected to be too 
low. The discrepancy between extinction coefficients calculated by the two protein assays 
could be due to variations of color response for the assays. The Modified Lowry assay could 
be more accurate [40], in addition extrapolation was performed to calculate protein 
concentration for the Bradford assay causing a higher uncertainty. 
3.1.8 Heme Assay 
The fraction of FHb with heme and FAD varies among organisms and purification runs, 
although the ratio between concentrations of FHb and heme can be 1:1 [42]. As heme absorbs 
light at 405 nm, the ratio between absorbance at 405 nm and 280 nm (OD405 / OD280) can 
indicate heme content. Takaya et. al. reported a ratio of 0.85 with 0.5 mole heme and 1 mole 
FAD per mole FHb [18]. Rafferty et. al. reported a ratio of 1.05 with 0.65 mole heme and 
1 mole FAD per mole FHb [22]. 
Heme assays were performed to quantify heme concentrations of FHb samples, and assess the 
amount of mole heme/mole protein (figure 3.15). For the assay, FHb is reduced with 
dithionite and reoxidized with ferricyanide. Heme concentrations in the samples are 
calculated from the absorbance differences of the reduced minus oxidized heme at 556 nm 
and 539 nm
M heme is given by the following formula: M heme = 46.7 (A556 – A539) [33, 35] 
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Figure 3.15: A typical UV-vis spectrum for a heme assay. Heme assay performed as described in Methods. 
Heme concentration is calculated by the formula: M heme = 46.7 (A556 – A539) The spectra are 
background corrected at 700 nm (700 nm = 0). 
 
The extinction coefficients for the Soret peak of FHbs from three organisms have been 
reported, which differ by a factor of 2: 403 = 88.6 mM
-1
cm
-1
 for E. coli, [34] 395 = 123 mM
-
1
cm
-1
 for R. eutropha [43] and 395 = 63 mM
-1
cm
-1
 for S. cerevisiae [24]. An extinction 
coefficient of 88.6 mM
-1
cm
-1
 has been used to calculate concentration of FHb with heme.  
The Soret peak of B. cereus FHb is at 405 nm, and E. coli has the Soret peak at the most 
similar wavelength (403 nm). 
It is worth to note that the FHb assayed contained a quite low 405 nm / 280 nm ratio (Table 
3.6). The heme assay gives a low concentration of heme compared to the concentration 
calculated from absorbance measurements. The heme fraction calculated from absorbance 
varies from 0.13 to 0.36. If the ratio between OD405/OD280 and heme content, is similar to that 
reported from Takaya et.al. [18] and Rafferty et.al. [22], then the expected heme fraction is 
0.15. This can indicate that the heme assay gives an underestimation of the heme content, and 
further studies have to be performed to validate the method. 
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Table 3.6: Results from heme assay 
280 280 
 
mM
-1
/cm
-1
 
 
[FHb] 
M 
[FHb-
Heme]* 
M 
 
[Heme] 
M 
Heme 
fraction* 
(405) 
Heme 
fraction 
(assay) 
OD405 
/OD280 
ProtParam 44.81 36.45 
4.74 1.14 
0.13 0.032 
0.26 
Bradford 70.36 23.02 0,21 0.050 
Lowry 124.02 13.17 0,36 0.087 
Assaysavg 89.78 18.18 0,26 0.063 
Concentrations of total protein [FHb] and heme fractions have been calculated with different extinction 
coefficients at 280 nm. Assaysavg is calculated from the average values of the protein assays. 
*Calculated with an extinction coefficient of 88.6 mM
-1
cm
-1
 [34].  
The FAD-content of FHb can vary, [33] and in order to measure FAD-content FHb was 
boiled and absorbance measured, but due to high background no conclusions can be drawn.  
However FAD content can be measured by fluorescence [33]. 
Reconstitution 
Reconstitution attempts were made by incubating the partly apo-FHb with either heme, FAD 
or both cofactors (figure 3.17-3.19). To separate the excess cofactor from the reconstituted 
FHb sample, an initial attempt was made by applying the sample to a desalting column as it is 
a crude size-exclusion column. However, only a single peak was observed, so the column was 
unable to separate protein from heme and other reactants, results not shown. Therefore, a 
Superdex 200 gel filtration column was used 
 
Figure 3.16: Reconstitution mixture applied on Superdex column: a) Solution used for reconstitution applied 
on a Superdex-200 GL column without FHb present. The black line, red line and blue line correspond to 400 nm, 
280 nm and 450 nm, respectively. 
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a) 
 
b) 
 
Figure 3.17: Reconstitution with heme: a) Chromatogram of reconstitution with heme. The black line, red line 
and blue line correspond to 400 nm, 280 nm and 450 nm, respectively. Four peaks are observed at 10 ml, 15 mL, 
20 mL and 27 mL. All peaks were collected and SDS-PAGE analysis was performed (b) as A3, A6, A9 and A11 
respectively. 
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Reconstitution with heme (figure 3.17) resulted in 4 peaks in the chromatogram and the peak 
at 15 mL is expected to be FHb as it shows a band at the expected size on the SDS-PAGE. 
The peaks at 20 mL and 27 mL are expected to be heme, as they are present when a heme 
solution is applied to the Superdex column, figure 3.16. The peak at 10 mL could be 
aggregates of FHb as filtration was not performed before application to the column, although 
no band is present in the SDS-gel. A UV-vis spectrum of the fraction however shows similar 
characteristics as FHb and the peak at 15 mL, but with a lower absorbance at 405 nm. A small 
peak at 13 mL might be catalase. The reconstitution clearly increased the heme content of the 
FHb as can be seen by the increase in 405 nm / 280 nm ratio from 0.72 to 0.99, from 0.38 to 
0.70 and 0.54 to 0.70 (Table 3.7). Therefore the reconstitution procedure of heme seemed to 
work. If compared to 405 nm / 280 nm ratios from other FHbs [18, 22], the heme content is 
expected to be 0.59 and 0.42 for the 405 nm / 280 nm ratios of 0.99 and 0.70, respectively. 
The Chromatogram from reconstitution with FAD (figure 3.18) also shows separation of 
protein from FAD with peaks at 15 mL and 20 mL, respectively. This is confirmed by SDS-
PAGE analysis as only the first peak contains a protein band. The tiny peak at 13 mL might 
be catalase. Table 3.7 shows an increase in absorbance at 450 nm, although lower than for 
heme which is expected as FAD has a lower extinction coefficient than heme at this 
wavelength (450  11.2 mM
-1
cm
-1
) [44]. FAD absorbs some light at 405 nm as well. 
As reconstitution with both heme and FAD separately indicate successful reconstitution a trial 
of reconstitution with heme and FAD by adding both cofactors to the same tube was tested.  
The chromatogram (figure 3.19) is a mixture of the former reconstitutions experiments with 
the expected peaks, in addition to a shoulder at 13 mL. The change in 405 nm / 280 nm ratio 
is similar as for reconstitution with heme alone with an additional increase in 450 nm / 280 
nm ratio, especially for the A7 peak. It seems like reconstitution of heme and FAD can be 
performed by adding both cofactors at the same time. An SDS-PAGE analysis should be 
performed, in addition to further testing to possibly increase the amount of holo-FHb further. 
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a) 
 
b) 
 
Figure 3.18: Reconstitution with FAD: a) Chromatogram of reconstitution with FAD, The black line, red line 
and blue line correspond to 400 nm, 280 nm and 450 nm, respectively. Two peaks are observed at 15 mL, 20 mL 
and 27 mL. Both peaks were collected and SDS-PAGE analysis was performed (b) as A6 and A10, respectively. 
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Figure 3.19: Reconstitution of heme and FAD at the same time: Chromatogram of reconstitution with heme 
and FAD. The black line, red line and blue line correspond to 400 nm, 280 nm and 450 nm, respectively. Four 
peaks are observed at 13 mL, 15 mL, 20 mL and 27 mL. The first two are collected as indicated on the figure. 
Table 3.7: 400 nm/280 nm 
  Before After 
Reconstitution Peak OD405/OD280 OD450/OD280 OD405/OD280 OD450/OD280 
Heme A6 0.72 0.15 0.99 0.25 
Heme A6 0.38 0.09 0.70 0.21 
Heme*,** A6 0.54 0.17 0.70 0.31 
FAD** A6 0.69 0.15 0.75 0.20 
Heme+FAD** 
A7 
0.72 0.16 
1.05 0.39 
A10 0.99 0.28 
*Performed at 4C, *Performed with 100 M FHb instead of 20 mM 
 
Sequence alignment 
A sequence alignment of B. cereus FHb (figure 3.31) was performed with flavohemoglobins 
from E. coli, R. Eutropha and S. cerevisiae with sequence identities of 46.72, 46.63 and 
44.53, respectively. The organisms listed all have crystal structure in the Protein data bank 
(PDB) [17, 24, 25]. The conserved residues mentioned in the introduction are all present in 
B. Cereus FHb. The FHb sequence alignment in addition to spectroscopy and SDS-PAGE 
analysis confirm that the purified protein is a member of the FHb family. 
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YHb      MLAEKTRSIIKATVPVLEQQGTVITRTFYKNMLTEHTELLNIFNRTNQKVGAQPNALATT 60 
FHp      MLTQKTKDIVKATAPVLAEHGYDIIKCFYQRMFEAHPELKNVFNMAHQEQGQQQQALARA 60 
FHb      MLSAKTIEIVKSTVPLLQEKGVEITTRFYQILFSEHPELLNIFNHTNQKKGRQQQALANA 60 
Hmp      MLDAQTIATVKATIPLLVETGPKLTAHFYDRMFTHNPELKEIFNMSNQRNGDQREALFNA 60 
         **  :*   :*:* *:* : *  :   **. ::  . ** ::** :.*. * * :**  : 
 
YHb      VLAAAKNIDDLSVLMDHVKQIGHKHRALQIKPEHYPIVGEYLLKAIKEVLGDAATPEIIN 120 
FHp      VYAYAENIEDPNSLMAVLKNIANKHASLGVKPEQYPIVGEHLLAAIKEVLGNAATDDIIS 120 
FHb      VYAAATYIDNLEAIIPVVKQIGHKHRSLGIKAEHYPIVGTCLLRAIKEVAGA--PDEVLN 118 
Hmp      IAAYASNIENLPALLPAVEKIAQKHTSFQIKPEQYNIVGEHLLATLDEMFSP--GQEVLD 118 
         : * *  *::   ::  :::*..** :: :* *:* ***  ** ::.*: .     :::. 
 
YHb      AWGEAYQAIADIFITVEKKMYEEA-----LWPGWKPFEITAKEYVASDIVEFTVKPKFGS 175 
FHp      AWAQAYGNLADVLMGMESELYERSAEQPGGWKGWRTFVIREKRPESDVITSFILEPADGG 180 
FHb      AWGEAYGVIADAFISIEAEMYEEAAHKEGGWKDFRNFVIVKKVKESDVITSFYLKPEDGG 178 
Hmp      AWGKAYGVLANVFINREAEIYNENASKAGGWEGTRDFRIVAKTPRSALITSFELEPVDGG 178 
         **.:**  :*: ::  * ::*:.       *   : * *  *   :  *..* ::*  *. 
 
YHb      GIELESLPITPGQYITVNTHPIRQENQYDALRHYSLCSASTKNGLRFAVKMEAARENFPA 235 
FHp      PV----VNFEPGQYTSVAIDVPA--LGLQQIRQYSLSDMPNGRSYRISVKREGGG-PQPP 233 
FHb      KV----SSFIPGQYVTIQINIEG--ETYTHNRQYSLSDAPGKEYYRISVKKEKGV-DTPD 231 
Hmp      AV----AEYRPGQYLGVWLKPEG--FPHQEIRQYSLTRKPDGKGYRIAVKREEG------ 226 
          :        ****  :  .           *:***      .  *::** * .       
 
YHb      GLVSEYLHKDAKVGDEIKLSAPAGDFAINKELIHQNEVPLVLLSSGVGVTPLLAMLEEQV 295 
FHp      GYVSNLLHDHVNVGDQVKLAAPYGSFHIDV----DAKTPIVLISGGVGLTPMVSMLKVAL 289 
FHb      GKVSNYLHGHVKEGDVLPVSAPAGDFVLNM----DSTLPVVLISGGVGITPMMSMLNTLI 287 
Hmp      GQVSNWLHNHANVGDVVKLVAPAGDFFMAV----ADDTPVTLISAGVGQTPMLAMLDTLA 282 
         * **: ** ..: ** : : ** *.* :          *:.*:*.*** **:::**.    
 
YHb      KCNPNRPIYWIQSSYDEKTQAFKKHVDELLAECANVDKIIV------------HTDTEPL 343 
FHp      -QAPPRQVVFVHGARNSAVHAMRDRLREAAKTYENLDLFVFYDQPLPEDVQGRDYDYPGL 348 
FHb      EQDSKRNVYFVHAAINSNTHAMKEHVKAVENEYEQVKAYTCYSAPTEKDLEMKNFDKEGF 347 
Hmp      KAGHTAQVNWFHAAENGDVHAFADEVKELGQSLPRFTAHTWYRQPSEADRAKGQFDSEGL 342 
                : :.:.: :  .:*: ..:        ..                 . *   : 
 
YHb      INAAFLKE-KSPAHADVYTCGSLAFMQAMIGHLKELEHRDDMIHYEPFGPKMSTVQV 399 
FHp      VDVKQIEKSILLPDADYYICGPIPFMRMQHDALKNLGIHEARIHYEVFGPDLFAE-- 403 
FHb      IESEWLKTIIPTTEAEFYFCGPVAFMKHINAALTDLSVKQEHIHYEFFGPATSLQ-- 402 
Hmp      MDLSKLEGAFSDPTMQFYLCGPVGFMQFTAKQLVDLGVKQENIHYECFGPHKVL--- 396 
         ::   ::        : * ** : **:     * :*  ::  **** ***        
 
 
Sequence identity to FHb 
Hmp: 46.72 
FHp: 46.63 
YHb: 44.53 
 
 
Figure 3.20: Sequence alignment of FHb. Sequence alignment of flavohemoglobin from B. cereus (FHb), 
S. cerevisiae (YHb), E. coli (Hmp), and R. Eutropha (FHp) performed by Clustal Omega [45]. An “*” (asterisk) 
indicates positions which have a single, fully conserved residue. A “:” (colon) and a “.” (period) indicate 
conservation between groups of strongly similar properties and weakly similar properties, respectively.  
Amino acids either surrounding the active site and/or are known to play a role in catalysis are marked in yellow. 
Amino acids in cyan are believed to constitute the push-and-pull mechanism. Side chains responsible for FAD 
binding are marked in green [13]. In addition amino acids otherwise mentioned in the introduction are marked in 
gray.  
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Protein crystallization 
For crystallization screening a range of different commercial crystallization kits were used 
(Table 3.8). Very small red or orange needles grew from amorphous precipitate under various 
conditions (figure 3.21) (Table 3.8). Optimization of crystallization conditions were set out 
manually under a light microscope. None of the initial crystals/needles were reproduced 
during optimization. FHb precipitated during mixing of the drops for crystallization which 
might be due to light sensitivity of the flavin as crystallization was performed under a light 
microscope. Flavins exhibit some light-sensitivity and are susceptible to photo-degradation, 
although FAD is less sensitive than the other flavins (by an order of magnitude). Regardless 
Nobre et al. and Zhou et al. performed purification of FHb protected from light and estimated 
mole heme per mole protein to be 1 and 0.89, respectively [20, 21]. 
In addition the ratio between OD400 and OD280 varied between each purification. A high 
purity and low apo-content (homogenous solution) is important for crystal growth. The 
relatively high apo-content could be one of the reasons for the limited success of the 
crystallization screening. To obtain a sample with higher holo-content, a successful 
reconstitution is one possibility, as well as being able to separate the apo- and holo-FHb 
during purification.  
A lack of diffracting crystals resulted in no X-ray data and consequently no crystal structure. 
 
 
Figure 3.21: Small needles grown from precipitate. The picture of needles grown from precipitate is taken 
with a light microscope. 
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Table 3.8: Commercial crystallization screens used for initial screening. 
Screen name Manufacturer Room Temperature 4C 
Crystal Screen 1+2 Hampton Research C2, F10 - 
Hampton Index I+II Hampton Research X - 
JCSG+ 
Molecular 
Dimensions 
A9*, B9*, D7, H4, 
H6, H7* 
D7 
MIDAS 
Molecular 
Dimension 
A5, A6 X 
Morpheus 
Molecular 
Dimensions 
X - 
Natrix Hampton Research X - 
Wizard I + II Jena Bioscience E3 - 
Wells with small needles are named while screens with no crystals are marked with an “X”. 
Table 3.9: Conditions with small needles grown from precipitate 
Screen name Well Contents 
Crystal Screen 1 + 2 C2 0.2 M Ammonium acetate, 0.1 M sodium citrate tribasic 
dehydrate pH 5.6 30% v/v MPD 
F10 0.1 M MES monohydrate pH 6.5 12% (w\v) PEG 20 000 
JCSG+ A9 0.2 Ammonium chloride pH 6.3 20% (w\v) PEG  3350 
B9 0.1 M Citric acid pH 5, 20% (w\v) PEG 6000 
D7 0.2 M Lithium sulfate, 0.1 M Tris pH 8.5, 
40% (w\v) PEG 400 
H4 0.2 M Calcium chloride, 0.1 M Bis-Tris pH 5,5, 
45% (w\v) MPD 
H6 0.1 M Ammonium acetate, 0.1 M Bis-Tris pH 5.5, 
17% PEG (w\v) 10 000 
H7 0.2 mM Ammonium sulfate, 0.1 M Bis-Tris pH 5.5, 
25% (w\v) PEG 3350 
MIDAS A5 0.5 M ammonium phosphate monobasic, 12.5% (w\v) 
poly(acrylic acid sodium salt) 2100 
A6 19% (v/v) poly(acrylic acid-co-maleic acid), 
0.1 M Tris pH 8.5 
Wizard I + II E3 20% (w/v) PEG 8000, 0.1 M Tris pH 8.5; 0.2 M MgCl2 
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Conclusion and future perspectives 
The focus of this master project was to purify, characterize and obtain a crystal structure of 
flavohemoglobin (FHb) from B. Cereus. FHb is an NO-dioxygenase which is proposed to 
protect against nitric oxide by dioxygenation of NO to nitrate (NO3
-
). As well as being a 
potential therapeutic target [13] it can be a useful tool for probing mammalian nitric oxide 
biology [16]. 
The protein was successfully cloned and expressed and a purification protocol has been 
developed, with ammonium sulfate precipitation, anion exchange chromatography and gel 
filtration. A high yield with high purity was obtained, but with varying degrees of heme and 
FAD content. Crystallization screening resulted in only some small needles grown from 
precipitate, and as reproduction or optimization of crystallization failed, no crystal structure 
was obtained.  
With varying degrees of apo-protein, heme assay was performed in order to identify heme to 
protein ratio. Bradford assay and Modified Lowry assay was used to obtain the protein 
concentration and calculate extinction coefficients. Testing of reconstitution of heme and 
FAD was performed with promising results.  Both heme and FAD content was clearly 
increased, in addition reconstitution of both cofactors can be performed at the same time. 
Future work includes reconstitution, more crystallization screening and further 
characterization. Purification protected from light should be tested as well. 
In summary, this thesis presents an expression and purification protocol and the first results of 
characterization and reconstitution of the flavohemoglobin protein from Bacillus Cereus. 
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4 Appendices 
Appendix 1 – Terms and abbreviations 
(v/v)   (volume/volume) 
(w/v)   (weight/volume) 
Amp   Ampicillin 
B. cereus  Bacillus cereus 
BSA   Bovine serum albumin 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
DTT   Dithiothreitol 
E. coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
EtOH   Ethanol 
FAD   Oxidized Flavin Adenine Dinucleotide 
FADH2  Reduced Flavin Adenine Dinucleotide 
FADSQ   Semiquinone state of Flavin Adenine Dinucleotide 
FHb   Flavohemoglobin 
hAC   Acetic Acid 
HEPES  N-2-hydroxyethylpiperazine-N’-2-ethanosulfonic acid 
H2O   water 
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IPTG   Isopropyl -D-1-Thiogalactopyranoside 
LB   Lysogeny broth 
MOPS   3-(N-morpholino)propanosulfonic acid 
MPD   2-methyl-2,4-pentanediol 
NAD+   Oxidized Nicotinamide adenine dinucleotide 
NADH  Reduced Nicotinamide adenine dinucleotide 
NADP+  Oxidized Nicotinamide adenine dinucleotide phosphate 
NADPH  Reduced Nicotinamide adenine dinucleotide phosphate 
N2   Nitrogen gas 
PAGE   Polyacrylamide gel electrophoresis 
PDB   Protein Data Bank 
PEG   Polyethylene glycol 
R. eutorpha  Ralstonia eutropha, formerly Alcaligenes eutrophus 
S. cerevisiae  Saccharomyces cerevisiae 
SDS   Sodium dodecyl sulfate 
TB   Terrific broth 
Tris   Tris(hydroxymethyl) aminomethane 
UV   Ultraviolet 
UV-vis  Ultraviolet-visible light 
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Appendix 2 – Materials 
Chemicals 
Chemical Manufacturer 
Acetic acid Merck 
-aminoluvelinic acid (ALA) Sigma 
Ammonia Kebo Lab 
Ammonium chloride Sigma / Merck 
Ammonium sulfate Merck 
Ampicillin sodium salt Sigma 
Bacto agar Becton, Dickinson & Co. 
Bovine Serum Albumin standard, prediluted GBiosciences 
Bradford Assay Dye Reagent Bio-Rad laboratories 
Brilliant Blue R250 Sigma 
Catalase Sigma 
Citric acid Fluka 
Deconex (Detergent) VWR 
DTT V'WR 
Ethylenediaminetetraacetic acid (EDTA) Sigma 
Ex-Cell Antifoam Sigma 
Dimethyl sulfoxide (DMSO) Sigma 
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Dithiothreitol (DTT) Sigma 
Ethanol Arcus 
FAD Sigma 
Glycerol VWR 
Hydrochloric acid  37% Sigma 
Hemin Fluka 
HEPES Sigma 
MOPS SDS-Running buffer Noves® 
Mucosit®-P Disinfecting Powder Cleaner Sigma 
NADPH Applichem 
NuPAGE ® Bis-Tris Mini Gels (10 & 15 wells) Novex® 
InstantBlue coomasie staining CBS 
Isopropyl -D-1-thiolgalactopyranoside (IPTG) Thermo 
PEG (3350, 6000 and 8000) Sigma 
Potassium chloride Merck 
Potassium ferricyanide Aldrich 
Dipotassium hydrogen phosphate (K2HPO4) Merck 
Potassium dihydrogenphosphate (KH2PO4) Merck 
Protease pill (cOMplete ULTRA tablets, mini Easypack) Roche 
Pyridine Merck 
Riboflavin (Vitamin B2) Sigma 
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Sodium dithionite Fluka 
Sodium citrate Merck 
Streptomycin sulfate salt Sigma 
Tris(hydroxymethyl)aminomethane (Tris) VWR 
Tryptone Sigma 
Yeast Extract Merck 
 
Chromatographic column materials 
Material Manufacturer 
Hitrap
 
Desalting GE Healthcare 
Sephadex 25 GE Healthcare 
HPQ Sepharose GE Healthcare 
Superdex 200 10/30 GL GE Healthcare 
Superdex 200 GE Healthcare 
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Hardware 
Material Function Manufacturer 
Äkta purifier system Purifier stystem GE Healthcare 
JA-10 rotor Rotor Beckman Coulter 
JA-25.50 rotor Rotor Beckman Coulter 
pH meter (PHM240) pH-meter Radiometer Analytical 
MililQ plus MilliQ-water Millipore 
Agilent 8453 Spectrophotmeter UV-vis 
spectrophotometer 
Agilent Technologies 
Series 25 Incubator shaker Incubator New Brunswich Sc. 
Tomy SS-325 Autoclave Tomy 
Emmer autoklav Autoclave Emmer 
Dri-Block DB-2D Heat block Techne 
WB4MS Water Bath Biosan 
REAX 2000 Vortex Heidolph 
Mosquito LCP Crystallization robot TTP Labtech 
Oryx6 Robot  Crystallization robot Douglas Inst. Ltd. 
Avanti J-25 Centrifuge Large centrifuge Beckman 
Avanti J-20XP Centriguge Large centrifuge Beckman Coulter 
BioCen20 Table centrifuge Orto Alresa 
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Software 
Material Source 
845 x UV visible Chem Station Agilent Technologies 
Unicorn 531 (build 743) 2011 Äkta GE Healthcare 
Unicorn 407 (build 743) 2006 Äkta GE Healthcare 
 
Equipment 
Material Manufacturer 
Amicon Ultra (30 K) Millipore 
Amicon Ultra 4 Centrifugal filters Millipore 
Amicon Plus-70 Centrifugal filters (30 K) Millipore 
Centrifugation tubes  Nalgene 
Crystallization plates Qiagen 
Cuvettes (Quartz) Hellmma 
Disposable cuvettes Plastibrand 
Microlance 3 BD 
PCR-Tubes Axygen 
Pipette tips VWR 
Precision syringes Hamilton 
Sterile 0.22 m filter Sarstedt  
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Crystallization Kits 
Screen name Manufacturer 
Crystal Screen Hampton Research 
Hampton Index I+II Hampton Research 
JCSG+ Qiagen / Molecular Dimensions 
MIDAS Molecular Dimensions 
Morpheus Molecular Dimensions 
Natrix Hampton Research 
Proplex Molecular Dimensions 
Wizard I + II Emerald Biosystems / Rigaku Reagents 
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Appendix 3 – Media and solutions 
 
4.1.1 Media 
 
LB-medium (1 L)     Phosphate Buffer    
10 g NaCl      0.17 M KH2-phosphate 
10 g tryptone      0.72 M K2H-phosphate 
5 g yeast extract     pH 7.5 
1 L MilliQ-water     autoclaved 
Adjusted to pH 7.5 and autoclaved 
 
TB-medium (1 L)           
12 g tryptone 
25 g yeast extract 
0.9 L MilliQ-water 
4 mL glycerol dissolved in water 
0.1 L phosphate buffer, pH 7.5 autoclaved separately  
Autoclaved without glycerol and phosphate buffer 
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4.1.2 Buffers 
 
Buffer A     Buffer B      
50 mM Tris-Cl, pH 7.5   1 M KCl 
50 mM Tris-Cl, pH 7.5   2 mM DTT 
2 mM DTT 
 
Buffer C     Buffer D      
100 mM HEPES, pH 7.5   50 mM Tris-Cl, pH 8 
100 mM KCl     1 mM EDTA 
2 mM DTT     10 mM DTT 
3000 U catalase 
 
Appendix 4 – Sequences 
Amino acid sequence of flavohemoglobin from B. cereus (402 aa) 
MLSAKTIEIV KSTVPLLQEK GVEITTRFYQ ILFSEHPELL NIFNHTNQKK 50 
GRQQQALANA VYAAATYIDN LEAIIPVVKQ IGHKHRSLGI KAEHYPIVGT 100 
CLLRAIKEVA GAPDEVLNAW GEAYGVIADA FISIEAEMYE EAAHKEGGWK 150 
DFRNFVIVKK VKESDVITSF YLKPEDGGKV SSFIPGQYVT IQINIEGETY 200 
THNRQYSLSD APGKEYYRIS VKKEKGVDTP DGKVSNYLHG HVKEGDVLPV 250 
SAPAGDFVLN MDSTLPVVLI SGGVGITPMM SMLNTLIEQD SKRNVYFVHA 300 
AINSNTHAMK EHVKAVENEY EQVKAYTCYS APTEKDLEMK NFDKEGFIES 350 
EWLKTIIPTT EAEFYFCGPV AFMKHINAAL TDLSVKQEHI HYEFFGPATS 400 
LQ         402 
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DNA sequence of flavohemoglobin from B. cereus (1209 bp for gene and 1257 bp total) 
TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGTTAAGTGCAAAAACAAT
TGAAATCGTAAAGTCAACAGTACCATTATTACAAGAAAAAGGTGTTGAAATTACAACGAGAT
TCTATCAAATTTTATTTTCGGAACATCCGGAATTGTTGAATATTTTCAACCATACGAATCAG
AAAAAGGGAAGACAACAACAAGCGTTAGCGAATGCTGTTTATGCAGCTGCAACGTACATTGA
TAATTTAGAAGCAATTATTCCAGTTGTAAAACAAATTGGTCATAAGCATAGAAGTTTAGGGA
TTAAAGCTGAGCATTATCCGATTGTAGGTACATGTTTACTACGTGCCATTAAAGAGGTCGCA
GGTGCACCTGATGAAGTTTTAAATGCATGGGGAGAAGCATATGGTGTAATTGCTGATGCATT
CATTAGCATTGAAGCAGAGATGTATGAAGAAGCTGCACATAAAGAAGGTGGATGGAAAGACT
TCCGCAACTTTGTGATTGTAAAAAAAGTGAAGGAAAGCGATGTTATTACGTCATTTTATTTG
AAACCTGAAGATGGAGGGAAAGTTTCTTCATTCATCCCAGGTCAATATGTAACAATTCAAAT
CAATATTGAAGGTGAGACATATACACATAATCGTCAATACAGTTTATCCGATGCTCCTGGGA
AAGAATATTATCGTATTAGTGTAAAAAAAGAAAAAGGTGTAGATACACCAGACGGTAAAGTG
TCTAATTACTTACATGGACATGTAAAAGAAGGAGATGTTTTACCAGTAAGTGCACCAGCGGG
AGATTTCGTGTTAAATATGGATTCAACATTACCAGTTGTACTAATTAGTGGTGGAGTGGGGA
TTACACCGATGATGAGTATGTTAAATACGTTAATTGAACAAGATTCAAAACGTAATGTATAT
TTTGTTCATGCAGCAATAAATAGTAATACACATGCAATGAAAGAACACGTTAAGGCAGTAGA
AAATGAATATGAACAAGTTAAAGCATATACTTGTTATTCTGCACCGACTGAAAAAGATTTAG
AAATGAAGAACTTTGATAAAGAAGGTTTCATTGAAAGTGAATGGTTAAAAACTATTATTCCG
ACAACTGAAGCAGAGTTCTATTTCTGTGGTCCAGTAGCATTTATGAAGCATATAAATGCTGC
ACTAACTGATTTAAGTGTGAAACAAGAGCATATTCATTATGAATTTTTCGGCCCAGCAACAA
GCTTACAATAAGGATCC 
Start and stop codon are marked in bold, Restriction sites for cutting are underlined and a part 
of the original vector sequence is shown in blue. 
The restriction enzymes have the following restriction sites: 
XbaI: TCTAGA  used for cutting 
BamHI: GGATCC  used for cutting 
NdeI:  CATATG  often used by the group 
NdeI was not used as a restriction enzyme as a restriction site is present within the protein 
sequence. In order to make minimal changes to the vector, the additional bases of the vector 
between the XbaI and NdeI were added. 
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Appendix 5 – Vector map 
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Appendix 6 – Gel filtration chromatograms 
An overview of the chromatograms in this section is found in the table below. Gel filtration 
has been performed as described in the Methods section. 
The figures names are given in this format: 
Figure “Letter”, “ammonium sulfate fraction”, “anion exchange program used” 
For the figures, the black line, red line and blue line correspond to 400 nm, 280 nm and 
450 nm, respectively. Protein with absorption at 400 nm is collected as indicated on the 
figures. 
Modified Table 3.1 Overview of anion-exchange experiments performed 
Fraction Gradient type Gradient IEX-chromatogram GF 
0.43 g/mL  
Linear 0-100% Fig. 3.4a - 
Linear 0-30% Fig 3.6a Figure A 
Step Step1 Fig 3.6b Figure B 
0.30 g/mL 
Linear 0-100% Fig 3.4b - 
Linear 0-50% Fig 3.7b Figure C 
Step Step1 Fig 3.7a Figure D 
Mix 
Linear 0-30% Fig. 3.9 - 
Step Step1 Fig. 3.8a Figure E 
Step Step2 Fig. 3.8b Figure F 
Apo* Step Step2 Fig. 3.8b Figure G 
*Collected from second half of the peak in figure 3.8b with very low absorbance at 400 nm. 
Figure A, 0.43 g/mL, 0-30% 
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Figure B, 0.43 g/mL, Step1 
 
Figure C, 0.30 g/mL, 0-50% 
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Figure D, 0.30 g/mL, Step1 
 
Figure E, Mix, Step1 
  
 
 
 
0 20 40 60 80 100 120 140
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
m
A
U
mL eluate
 400 nm
 450 nm
 450 nm
Collected
0 20 40 60 80 100 120 140 160
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400
m
A
U
mL eluate
 400 nm
 280 nm
 450 nm
Collected
66 
 
Figure F, Mix, Step2 
 
Figure G, Mix (Apo*), Step2 
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